Crossmark

Computational prognostic evaluation of Alzheimer’s drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches

Crossref DOI link: https://doi.org/10.1038/s41598-023-45347-1

Published Online: 2023-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassan, Mubashir

Shahzadi, Saba

Yasir, Muhammad

Chun, Wanjoo

Kloczkowski, Andrzej
License Information

Text and Data Mining valid from 2023-10-21

Version of Record valid from 2023-10-21
More Information

Article History

Received: 24 March 2023

Accepted: 18 October 2023

First Online: 21 October 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below